Collateral Ventilation Measurement Using Chartis: Procedural Sedation vs General Anesthesia.


Journal

Chest
ISSN: 1931-3543
Titre abrégé: Chest
Pays: United States
ID NLM: 0231335

Informations de publication

Date de publication:
11 2019
Historique:
received: 08 05 2019
revised: 02 07 2019
accepted: 31 07 2019
pubmed: 20 8 2019
medline: 23 6 2020
entrez: 18 8 2019
Statut: ppublish

Résumé

Absence of interlobar collateral ventilation is key to successful endobronchial valve treatment in patients with severe emphysema and can be functionally assessed by using the Chartis measurement. This system has been validated during spontaneous breathing, undergoing procedural sedation (PS), but can also be performed under general anesthesia. Performing the Chartis measurement under PS is often challenging because of coughing, mucus secretion, and difficulties in maintaining an adequate level of sedation. The objective of this study was to investigate whether there is a difference in Chartis measurement outcomes between PS and general anesthesia. In this prospective study, patients underwent Chartis measurements under both PS and general anesthesia. Study outcomes were Chartis measurement duration, number of measurements, feasibility, and success rate. The study included 30 patients with severe emphysema (mean age, 62 years; median FEV This study found that Chartis measurement under general anesthesia is faster and more feasible to perform compared with performance with PS, without affecting measurement outcomes. Clinicaltrials.gov; No. NCT03205826; URL: www.clinicaltrials.gov.

Sections du résumé

BACKGROUND
Absence of interlobar collateral ventilation is key to successful endobronchial valve treatment in patients with severe emphysema and can be functionally assessed by using the Chartis measurement. This system has been validated during spontaneous breathing, undergoing procedural sedation (PS), but can also be performed under general anesthesia. Performing the Chartis measurement under PS is often challenging because of coughing, mucus secretion, and difficulties in maintaining an adequate level of sedation. The objective of this study was to investigate whether there is a difference in Chartis measurement outcomes between PS and general anesthesia.
METHODS
In this prospective study, patients underwent Chartis measurements under both PS and general anesthesia. Study outcomes were Chartis measurement duration, number of measurements, feasibility, and success rate.
RESULTS
The study included 30 patients with severe emphysema (mean age, 62 years; median FEV
CONCLUSIONS
This study found that Chartis measurement under general anesthesia is faster and more feasible to perform compared with performance with PS, without affecting measurement outcomes.
TRIAL REGISTRATION
Clinicaltrials.gov; No. NCT03205826; URL: www.clinicaltrials.gov.

Identifiants

pubmed: 31421111
pii: S0012-3692(19)31455-2
doi: 10.1016/j.chest.2019.07.025
pii:
doi:

Banques de données

ClinicalTrials.gov
['NCT03205826']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

984-990

Informations de copyright

Copyright © 2019 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.

Auteurs

Jorrit B A Welling (JBA)

Department of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands; Groningen Research Institute for Asthma and COPD, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. Electronic address: j.b.a.welling@umcg.nl.

Karin Klooster (K)

Department of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands; Groningen Research Institute for Asthma and COPD, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Jorine E Hartman (JE)

Department of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands; Groningen Research Institute for Asthma and COPD, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Huib A M Kerstjens (HAM)

Department of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands; Groningen Research Institute for Asthma and COPD, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Ina Franz (I)

Department of Anaesthesiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Michel M R F Struys (MMRF)

Department of Anaesthesiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Anthony R Absalom (AR)

Department of Anaesthesiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Dirk-Jan Slebos (DJ)

Department of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands; Groningen Research Institute for Asthma and COPD, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Clemens R M Barends (CRM)

Department of Anaesthesiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH